OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Chad Dickey

1 Projects | 1 Researchers | $150,000 Invested

2011

University of South Florida

Chad Dickey, PhD

A Novel Enantiomeric Diarylheptanoid Derived from Myrica cerifera as an Anti-Tau Therapeutic

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed